Briviact 50474-0970-75
Generic: Brivaracetam
- Manufacturer
- Ucb, Inc.
- Dosage Form
- Injection, Suspension
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- May 12, 2016
- Listing Expires
- December 31, 2027
- Application
- NDA205837
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brivaracetam | 50 mg/5mL |
Drug Class
Epoxide Hydrolase Inhibitors [MoA]
Selected Package
50474-0970-75Selected10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63)